References
- Cohen L. Risperidone. Pharmacotherapy 1994; 14: 253–265
- Leysen J E, Gommeren W, Eens A. The biochemical profile of risperidone. a new antipsychotic. Journal of Pharmacology and Experimental Therapeutics 1988; 247: 661–670
- Ereshefsky L, Lacombe S. Pharmacologic profile of risperidone. Canadian Journal of Psychiatry 1993; 38(Suppl. 3)580–588
- Marder S R, Meibach R C. Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 1994; 151: 825–835
- Chouinard G, Jones B, Remington G, et al. A Canadian multi-centre placebo controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology 1993; 13: 25–40
- Alzaid K, Jones B D. A case report of risperidone induced obsessive compulsive symptoms. Journal of Clinical Psychopharmacology 1997; 17: 58–59
- Kopala L, Homer W G. Risperidone, serotonergic mechanisms and obsessive compulsive symptoms in schizophrenia. American Journal of Psychiatry 1994; 151: 1714–1715
- Remington G, Adams M. Risperidone and obsessive compulsive symptoms. Journal of Clinical Psychopharmacology 1994; 14: 358–359
- Patil V J. Development of transient obsessive compulsive symptoms during treatment with clozapine [letter]. American Journal of Psychiatry 1992; 149: 272
- Baker R W, Chengappa R, Bird J, Steingard S, Christ M, Schooler N. Emergence of obsessive compulsive symptoms during treatment with clozapine. Journal of Clinical Psychiatry 1992; 53: 439–442